0001127602-24-020038.txt : 20240703
0001127602-24-020038.hdr.sgml : 20240703
20240703150414
ACCESSION NUMBER: 0001127602-24-020038
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240703
DATE AS OF CHANGE: 20240703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hykes Andrew
CENTRAL INDEX KEY: 0001806431
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 241099742
MAIL ADDRESS:
STREET 1: C/O INARI MEDICAL, INC.
STREET 2: 9 PARKER AVENUE, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inari Medical, Inc.
CENTRAL INDEX KEY: 0001531048
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 452902923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-923-4747
MAIL ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Inceptus Newco1 Inc.
DATE OF NAME CHANGE: 20110923
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-07-01
0001531048
Inari Medical, Inc.
NARI
0001806431
Hykes Andrew
C/O INARI MEDICAL, INC.
6001 OAK CANYON
IRVINE
CA
92618
1
1
President and CEO
1
Common Stock
2024-07-01
4
S
0
3000
50.08
D
462474
D
Common Stock
2024-07-01
4
F
0
508
50.19
D
461966
D
Common Stock
2024-07-01
4
F
0
947
50.19
D
461019
D
Common Stock
2024-07-01
4
F
0
1475
50.19
D
459544
D
Common Stock
2024-07-01
4
F
0
1292
50.19
D
458252
D
Common Stock
1550
I
By Child 1
Common Stock
1550
I
By Child 2
Common Stock
1550
I
By Child 3
Common Stock
1000
I
By Spouse
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023.
This transaction was executed in multiple trades at prices ranging from $50.00 to $50.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021.
Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022.
Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023.
Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024.
/s/ Shannon Trevino, attorney-in-fact for Andrew Hykes
2024-07-03